Source:http://linkedlifedata.com/resource/pubmed/id/11251890
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2001-3-19
|
pubmed:abstractText |
Midtrimester amniotic fluid cytokines may reflect the function of the maternal immune system in the maternal-fetal interface and thus be predictive of pre-eclampsia. We determined the concentrations of interleukin (IL)-6, IL-8, IL-10, IL-11, IL-12, IL-15, tumour necrosis factor (TNF)-alpha and transforming growth factor (TGF)-beta in amniotic fluid at 14-16 weeks of gestation from women with normal pregnancies and from those who subsequently developed severe pre-eclampsia. The concentrations of the cytokines in amniotic fluid did not significantly differ between patients and normal controls. The median concentration of IL-6 was 950 pg/ml in normal pregnant women and 578 pg/ml in the patient group. The median concentration of IL-8 was 606 pg/ml in normal controls and 294 pg/ml in the patient group. The levels of IL-6, IL-8 and TGF-beta correlated positively with each other. TNF-alpha concentrations were low and similar in both groups. IL-10 and IL-12 were detected at very low levels in 37 and 7% of the samples, respectively. No difference was found in IL-15 concentrations between the groups. IL-11 was found only at low levels in both groups. Although none of the cytokines measured was predictive of pre-eclampsia, this study provides information of cytokines in amniotic fluid during the period when the spiral arteries are remodelled.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Cytokines,
http://linkedlifedata.com/resource/pubmed/chemical/Inflammation Mediators,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-12,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-15,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukins,
http://linkedlifedata.com/resource/pubmed/chemical/Transforming Growth Factor beta,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Necrosis Factor-alpha
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0300-9475
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
53
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
310-4
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11251890-Adult,
pubmed-meshheading:11251890-Amniotic Fluid,
pubmed-meshheading:11251890-Case-Control Studies,
pubmed-meshheading:11251890-Cytokines,
pubmed-meshheading:11251890-Female,
pubmed-meshheading:11251890-Humans,
pubmed-meshheading:11251890-Inflammation Mediators,
pubmed-meshheading:11251890-Interleukin-12,
pubmed-meshheading:11251890-Interleukin-15,
pubmed-meshheading:11251890-Interleukins,
pubmed-meshheading:11251890-Pre-Eclampsia,
pubmed-meshheading:11251890-Pregnancy,
pubmed-meshheading:11251890-Pregnancy Trimester, Second,
pubmed-meshheading:11251890-Transforming Growth Factor beta,
pubmed-meshheading:11251890-Tumor Necrosis Factor-alpha
|
pubmed:year |
2001
|
pubmed:articleTitle |
Cytokine levels in midtrimester amniotic fluid in normal pregnancy and in the prediction of pre-eclampsia.
|
pubmed:affiliation |
Turku Graduate School of Biomedical Sciences, Department of Medical Microbiology, Turku University, Kiinamyllynkatu 13, FIN-20520 Turku, Finland. jenni.heikkinen@utu.fi
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|